Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-21-056829
Filing Date
2021-11-05
Accepted
2021-11-04 18:43:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A ea150014-defa14a_actinium.htm DEFA14A 42038
  Complete submission text file 0001213900-21-056829.txt   43105
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36374 | Film No.: 211381628
SIC: 2834 Pharmaceutical Preparations